Evidence map›Paper›PMID 39519811›Full record

ArticleMolecules (Basel, Switzerland)2024

Synthesis of

Dorota Olender, Anna Pawełczyk, Anna Leśków, Katarzyna Sowa-Kasprzak, Lucjusz Zaprutko, Dorota Diakowska

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dorota OlenderChair and Department of Organic Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.ORCID 0000-0001-8320-5201
Anna PawełczykChair and Department of Organic Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.ORCID 0000-0003-4108-6499
Anna LeśkówDepartment of Medical Biology, Wroclaw Medical University, Chalubinskiego 3, 50-368 Wrocław, Poland.ORCID 0000-0002-3826-0452
Katarzyna Sowa-KasprzakChair and Department of Organic Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.ORCID 0000-0002-7419-945X
Lucjusz ZaprutkoChair and Department of Organic Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.ORCID 0000-0003-1121-6272
Dorota DiakowskaDepartment of Medical Biology, Wroclaw Medical University, Chalubinskiego 3, 50-368 Wrocław, Poland.ORCID 0000-0002-1377-5601

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chalcone is an aromatic ketone that forms the central core of many important biological compounds. Chalcone derivatives show various biological activities, especially anti-inflammatory, antibacterial, antioxidant, and anticancer activities, and also inhibit melanoma cell growth. In this study, we synthesized chalcone compounds with

Indexed as

Antineoplastic AgentsChalconesGreen Chemistry TechnologyMelanomaMicrowavesCell Line, TumorCell ProliferationCell SurvivalHumansAntineoplastic AgentsChalconesanticancer activitybis-chalconesClaisen–Schmidt reactioncytotoxicitygreen chemistrymicrowave- and ultrasound-assisted synthesis

Identifiers

PMID39519811
PMCPMC11547983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.